[Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
D000293:Adolescent; D001249:Asthma / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D009921:Metaproterenol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use*; D012118:Resorcinols / Q000627:therapeutic use*
D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol
Klinische Erfahrungen mit einem beta 2-Rezeptorenstimulans bei spastischen Lungenaffektionen in der Kinderheilkunde.